The ORATOR trial found no significant difference in survival outcomes between radiation therapy and transoral robotic surgery for HPV-related oropharyngeal cancer. Radiation therapy patients ...
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study This phase II trial of ...
A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has successfully tested a new robotic surgical system for treating head and neck ...
Compared with standard concurrent chemoradiation, neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to superior distant metastasis-free and overall ...
Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ oropharyngeal cancer.
In recent years, advancements in medical technology have significantly evolved heart treatment, offering safer and more effective options for patients. One of the most notable developments is using ...
A trial including 162 patients showed that surgeon-performed transoral/transcervical ultrasonography (USG) achieved a diagnostic accuracy of 86%, outperforming clinical examination and MRI (68% and 76 ...
In the ever-evolving landscape of healthcare technology, robotic surgery has emerged as a groundbreaking innovation, offering unprecedented precision and control in surgical procedures. Leading ...
Please provide your email address to receive an email when new articles are posted on . Robotic-assisted total hip arthroplasty was linked with increased costs and surgical complications compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results